DekaBank Deutsche Girozentrale’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,000
| Closed | -$486K | – | 1433 |
|
|
2021
Q1 | $486K | Hold |
13,000
| – | – | ﹤0.01% | 1036 |
|
|
2020
Q4 | $232K | Buy |
+13,000
| New | +$163K | ﹤0.01% | 1162 |
|
|
2019
Q3 | – | Sell |
-22,800
| Closed | -$138K | – | 1163 |
|
|
2019
Q2 | $138K | Sell |
22,800
-261,400
| -92% | -$2.5M | ﹤0.01% | 1054 |
|
|
2019
Q1 | $4.02M | Buy |
284,200
+272,800
| +2,393% | +$3.11M | 0.02% | 471 |
|
|
2018
Q4 | $97K | Sell |
11,400
-272,800
| -96% | -$3.25M | ﹤0.01% | 1061 |
|
|
2018
Q3 | $4.02M | Buy |
284,200
+270,000
| +1,901% | +$4.02M | 0.02% | 478 |
|
|
2018
Q2 | $221K | Sell |
14,200
-260,000
| -95% | -$4.54M | ﹤0.01% | 1032 |
|
|
2018
Q1 | $4.46M | Buy |
274,200
+143,700
| +110% | +$2.8M | 0.03% | 415 |
|
|
2017
Q4 | $3.72M | Hold |
130,500
| – | – | 0.03% | 425 |
|
|
2017
Q3 | $3.72M | Hold |
130,500
| – | – | 0.03% | 429 |
|
|
2017
Q2 | $4.12M | Buy |
130,500
+116,000
| +800% | +$3.62M | 0.03% | 414 |
|
|
2017
Q1 | $533K | Sell |
14,500
-1,200
| -8% | -$52.9K | ﹤0.01% | 730 |
|
|
2016
Q4 | $788K | Buy |
15,700
+1,200
| +8% | +$63K | 0.01% | 579 |
|
|
2016
Q3 | $752K | Hold |
14,500
| – | – | 0.01% | 598 |
|
|
2016
Q2 | $604K | Buy |
14,500
+2,700
| +23% | +$117K | 0.01% | 648 |
|
|
2016
Q1 | $470K | Sell |
11,800
-1,300
| -10% | -$44.7K | 0.01% | 666 |
|
|
2015
Q4 | $545K | Buy |
13,100
+200
| +2% | +$6.7K | 0.01% | 679 |
|
|
2015
Q3 | $199K | Buy |
12,900
+700
| +6% | +$15K | ﹤0.01% | 872 |
|
|
2015
Q2 | $303K | Buy |
12,200
+500
| +4% | +$11.1K | ﹤0.01% | 801 |
|
|
2015
Q1 | $267K | Buy |
+11,700
| New | +$295K | ﹤0.01% | 840 |
|
DekaBank Deutsche Girozentrale's FPRX Position: Q2 2021 in Review
DekaBank Deutsche Girozentrale sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 13,000 shares — an estimated $486K sold.
DekaBank Deutsche Girozentrale first reported a position in FPRX in Q1 2015 and held it in 20 quarters. The position peaked at $4.46M in Q1 2018. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- DekaBank Deutsche Girozentrale reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 13,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $486K.
- DekaBank Deutsche Girozentrale first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 20 quarters.
- DekaBank Deutsche Girozentrale's Five Prime Therapeutics, Inc. position peaked at $4.46M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.